CRSP
Price
$48.29
Change
-$0.71 (-1.45%)
Updated
Oct 17 closing price
12 days until earnings call
TGTX
Price
$23.94
Change
-$0.56 (-2.29%)
Updated
Oct 17 closing price
25 days until earnings call
Ad is loading...

CRSP vs TGTX

Header iconCRSP vs TGTX Comparison
Open Charts CRSP vs TGTXBanner chart's image
CRISPR Therapeutics AG
Price$48.29
Change-$0.71 (-1.45%)
Volume$1.15M
CapitalizationN/A
TG Therapeutics
Price$23.94
Change-$0.56 (-2.29%)
Volume$1.71M
CapitalizationN/A
View a ticker or compare two or three
CRSP vs TGTX Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRSP vs. TGTX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Sell and TGTX is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (CRSP: $48.29 vs. TGTX: $23.94)
Brand notoriety: CRSP and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 114% vs. TGTX: 45%
Market capitalization -- CRSP: $4B vs. TGTX: $3.69B
CRSP [@Biotechnology] is valued at $4B. TGTX’s [@Biotechnology] market capitalization is $3.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while TGTX’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 3 bearish.
  • TGTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than TGTX.

Price Growth

CRSP (@Biotechnology) experienced а +6.39% price change this week, while TGTX (@Biotechnology) price change was +9.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

TGTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4B) has a higher market cap than TGTX($3.69B). TGTX YTD gains are higher at: 40.164 vs. CRSP (-22.859). TGTX has higher annual earnings (EBITDA): 109M vs. CRSP (-335.17M). CRSP has more cash in the bank: 484M vs. TGTX (217M). TGTX has less debt than CRSP: TGTX (113M) vs CRSP (231M). TGTX has higher revenues than CRSP: TGTX (347M) vs CRSP (200M).
CRSPTGTXCRSP / TGTX
Capitalization4B3.69B108%
EBITDA-335.17M109M-307%
Gain YTD-22.85940.164-57%
P/E RatioN/A34.38-
Revenue200M347M58%
Total Cash484M217M223%
Total Debt231M113M204%
FUNDAMENTALS RATINGS
CRSP vs TGTX: Fundamental Ratings
CRSP
TGTX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
9664
SMR RATING
1..100
9314
PRICE GROWTH RATING
1..100
6036
P/E GROWTH RATING
1..100
8599
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (63) in the Biotechnology industry is in the same range as TGTX (84). This means that CRSP’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as CRSP (96). This means that TGTX’s stock grew similarly to CRSP’s over the last 12 months.

TGTX's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for CRSP (93). This means that TGTX’s stock grew significantly faster than CRSP’s over the last 12 months.

TGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as CRSP (60). This means that TGTX’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (85) in the Biotechnology industry is in the same range as TGTX (99). This means that CRSP’s stock grew similarly to TGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPTGTX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.45%
BEAM - CRSP
73%
Closely correlated
-8.77%
NTLA - CRSP
71%
Closely correlated
+1.94%
EDIT - CRSP
68%
Closely correlated
-4.06%
PRME - CRSP
58%
Loosely correlated
-4.04%
RXRX - CRSP
57%
Loosely correlated
-6.56%
More